GlassScriptPhysician profile
Theodore Tucker
NPI 1831187269
$752.86
in general payments reported to CMS, 2019-2025
12 companies · $24.61 in 2025
The $24.61 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.72 · 2020: $105 · 2021: $279 · 2022: $98.28 · 2023: $113 · 2024: $39.85 · 2025: $24.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $178.58 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $135.89 | 2021-2023 | Qulipta, Ubrelvy |
| Pfizer INC. | $95.13 | 2019-2021 | |
| Lilly USA, LLC | $72.26 | 2021-2023 | Trulicity, Mounjaro |
| Glaxosmithkline, LLC. | $58.02 | 2019-2022 | |
| Astellas Pharma US INC | $52.58 | 2020-2021 | |
| Abbott Laboratories | $45.32 | 2023-2025 | Freestyle Libre 3, Epic |
| Vanda Pharmaceuticals INC. | $39.85 | 2024 | Fanapt |
| Astrazeneca Pharmaceuticals LP | $30.22 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.30 | 2020 | |
| Allergan, INC. | $16.07 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.